GlassScriptPhysician profile
Adriane Hohmann
NPI 1922484211
$1,255.61
in general payments reported to CMS, 2019-2025
10 companies · $531 in 2025
The $531 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $42.62 · 2021: $18.30 · 2022: $19.94 · 2023: $153 · 2024: $149 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $203.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $369.62 | 2019-2025 | Total30, Eysuvis, Dailies Total1 |
| Coopervision INC. | $298.66 | 2019-2025 | Misight Contact Lens |
| Bausch & Lomb Americas INC. | $197.67 | 2023-2025 | Vyzulta, Miebo, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $131.68 | 2019 | |
| Sun Pharmaceutical Industries INC. | $101.73 | 2023-2025 | Cequa |
| Harrow Eye, LLC | $60.23 | 2025 | Vevye |
| Thea Pharma INC. | $34.60 | 2023 | Iyuzeh |
| Dompe US, INC. | $30.44 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $16.51 | 2023 | Tyrvaya |
| Biotissue Holdings INC. | $14.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adriane Hohmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.